New Therapies for Advanced Parkinson's Disease Faculty Bios
Mark Stacy, MD
Mark Stacy is a Professor of Neurology and the Associate Dean of Clinical Research in the School of Medicine at Duke University. He is also the Director of the Neuroscience Clinical Research Organization at Duke University. He has been named to "Best Doctors in America." Dr. Stacy is a fellow in the American Academy of Neurology, and sits on the Board of Directors of WE MOVE, a not-for-profit foundation dedicated to education in Movement Disorders. He is a member of the Parkinson Study Group, Dystonia Study Group and Tremor Study Group, and serves on the Medical Advisory Boards for the Benign Essential Blepharospasm Research Foundation and the International Essential Tremor Foundation. Dr. Stacy has clinical trial experience in Parkinson's Disease (PD), Dystonia, and Tremor and has served on numerous protocol steering committees and Safety Monitoring Boards. His independent research interests include motor and non-motor symptoms of wearing off, and pathological gambling and other impulse control disorders in PD. He has published manuscripts in the areas of PD, dystonia, tremor and other movement disorders. He is also the editor of The Handbook of Dystonia.
Lawrence Elmer, MD, PhD
University of Toledo
Lawrence Elmer joined the faculty of the University of Toledo College of medicine in 1998 where he holds the position of Professor of Neurology and Medical Director of the Center for Neurological Health. He is also director of the Parkinson's Disease and Movement Disorder Program within the Department of Neurology. He has served in a variety of leadership positions throughout the University, recently as President of the Faculty Senate at the University of Toledo Health Science Campus. Dr. Elmer speaks frequently at patient and medical education programs throughout the region and country. Dr. Elmer's research is primarily focused on emerging medical treatments for Parkinson's disease. His career passion involves caring for people with Parkinson's disease and their families, giving them the opportunity to deal successfully with this disease and enjoy life to the fullest.
Joseph Friedman, MD
Joseph Friedman is a Clinical Professor of Neurology in the Department of Clinical Neurosciences at Brown University Medical School. He is also the Director of NeuroHealth Parkinson's Disease and Movement Disorders Center in Warwick, Rhode Island. He is also the Editor in Chief of Medicine and Health, Rhode Island (the state medical journal, a joint publication of the Rhode Island Medical Society, Brown University, the Rhode Island Dept of Health and Rhode Island Quality Partners). Dr. Friedman is also an elected member of the American Academy of Neurology Movement Disorders Section Executive Committee, and a fellow of the American Academy of Neurology Movement. In addition, Dr. Friedman is the clinical director of the American Parkinson Disease Association information and referral center in Rhode Island.Dr. Friedman pursues clinical research related to movement disorders, primarily Parkinson's disease, but also Huntington's disease, drug induced movement disorders, disease, etc. He has been involved in studying behavioral aspects of Parkinson's disease as his main focus. He is also interested in drug induced movement disorders, particularly those induced by antipsychotic drugs.
Jennifer Goldman, MD
Rush University Medical Center
Jennifer G. Goldman is a member of the American Academy of Neurology, Movement Disorders Society, Parkinson's Study Group, and Society for Neuroscience and serves on the Parkinson's Study Group Cognitive/Behavioral Core Dataset Task Force, the Movement Disorders Society Task Force on Parkinson's disease-Mild Cognitive Impairment, and the Musicians with Dystonia Medical Advisory Committee of the Dystonia Medical Research Foundation. Dr. Goldman is an Assistant Professor in the Department of Neurological Sciences, Section of Movement Disorders at Rush University Medical Center in Chicago, IL. As a movement disorder specialist, Dr. Goldman treats patients with Parkinson's disease, dementia with Lewy bodies, atypical parkinsonism, occupational dystonias, and ataxia. Her research focuses on cognitive and neuropsychiatric features of Parkinson's disease and dementia with Lewy bodies. She is the recipient of a NIH K23 career development award to investigate cognitive dysfunction in Parkinson's disease using structural neuroimaging techniques and clinical measures.
Robert Hauser, MD, MBA
University of South Florida
Robert A. Hauser, MD, MBA, is Professor of Neurology, Molecular Pharmacology and Physiology at the University of South Florida. He is Director of the Parkinson's Disease and Movement Disorders Center, and Director of the Clinical Signature Interdisciplinary Program in Neuroscience. Dr. Hauser's research focuses on the development of new treatments for Parkinson's disease and other movement disorders. His expertise includes clinical trial design and execution. Dr. Hauser has authored or co-authored more than 150 peer-reviewed publications and has lectured frequently at scientific meetings around the world. He is a Past Chairman of the Interventional Neurology Section of the American Academy of Neurology, and has served on the executive committee of the Parkinson Study Group.
William Ondo, MD
Baylor College of Medicine
Dr. William G. Ondo attended medical school at the Medical College of Virginia, internship at the University of North Carolina, and underwent his neurology residency at Duke University. In 1995, Dr. Ondo undertook a movement disorders fellowship with Dr. Jankovic, and joined the Baylor faculty the following year. His interests include all areas of adult and pediatric movement disorders. He is particularly known for research in restless legs syndrome, Parkinson's disease, tremor, and the use of botulinum toxins.
Burton Scott, MD, PhD
Burton Scott, MD, PhD, is an Associate Clinical Professor in the Division of Neurology at Duke University. He earned an MD degree from the University of Miami School of Medicine in 1990 and completed residency training in neurology at Duke in 1994. He completed fellowship training in movement disorders with Dr. Joseph Jankovic in Houston, Texas, and returned to the Duke Neurology faculty in 1995. Dr. Scott has a special interest in the management and treatment of a variety of movement disorders including Parkinson's disease, and is an investigator for several clinical trials in movement disorders.
Daniel Weintraub, MD
University of Pennsylvania
Dr. Weintraub is Associate Professor of Psychiatry and Neurology at the University of Pennsylvania and Psychiatrist at the Parkinson's Disease Research, Education and Clinical Center at the Philadelphia Veterans Affairs Medical Center. A board-certified geriatric psychiatrist, he conducts clinical research in the psychiatric and cognitive complications of Parkinson's disease and Alzheimer's disease, and is author more than 50 original research articles. He completed a NIMH Career Development Award titled "Depression Diagnosis and Treatment in Parkinson Disease", and has also been Principal Investigator on grants from the VA, the Institute of Aging at Penn, the Fox Foundation for Parkinson's Research, and several industry-sponsored studies. Dr. Weintraub is on the Editorial Board of Movement Disorders, has been a member of 4 Movement Disorder Society (MDS) task forces to revise and make recommendations for the assessment of cognitive and psychiatric symptoms in Parkinson's disease, and is Chair of the Psychiatry Subgroup of the NINDS Common Data Elements (CDE) project.